Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients

BACKGROUND: Elevated symmetric dimethylarginine (SDMA) has been shown to predict cardiovascular events and all cause mortality in diverse populations. The potential role of SDMA as a risk marker in renal transplant recipients (RTR) has not been investigated. METHODS: We analyzed SDMA in the placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pihlstrøm, Hege, Mjøen, Geir, Dahle, Dag Olav, Pilz, Stefan, Midtvedt, Karsten, März, Winfried, Abedini, Sadollah, Holme, Ingar, Fellström, Bengt, Jardine, Alan, Holdaas, Hallvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240460/
https://www.ncbi.nlm.nih.gov/pubmed/24999963
http://dx.doi.org/10.1097/TP.0000000000000205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240460/
https://www.ncbi.nlm.nih.gov/pubmed/24999963
http://dx.doi.org/10.1097/TP.0000000000000205

Ejemplares similares